Business Context and Reporting Period
Company: CorMedix Inc. (CRMD)
Filing Type: Form 8-K (Current Report)
Date of Report: October 20, 2025
Reporting Period: Preliminary financial results for the quarter ended September 30, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that preliminary results were announced via a press release (Exhibit 99.1), which is incorporated by reference but not detailed within the body of this 8-K text.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the text of this filing. The document states that the preliminary results are subject to adjustment upon completion of accounting procedures.
Guidance, Outlook, and Risks
- Management Commentary: The Company issued a press release on October 20, 2025, announcing preliminary results.
- Contingencies: The reported figures are preliminary and subject to adjustment.
- Risks: No specific risk factors or unusual items are detailed in the text of this filing.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific financial figures, as they are not included in the 8-K text.
- Verify the final audited or reviewed financial statements once accounting procedures are complete, as current figures are preliminary.
- Confirm the trading status of Common Stock on the Nasdaq Global Market.